Vitamin D Levels in Patients with Active and Remission Graves' Disease. 2023

Natapon Rattanamusik, and Suriyon Uitrakul, and Atchara Charoenpiriya
Department of Medicine, Maharaj Nakhon Si Thammarat Hospital, Nakhon Si Thammarat 80000, Thailand.

BACKGROUND The association between Graves' disease (GD) and serum vitamin D levels has been studied for decades although the results were controversial. Moreover, the difference in vitamin D levels between the different stages of GD is not well studied. Therefore, this study aimed to compare the vitamin D levels between active and remission GD and to investigate the factors affecting vitamin D levels in GD patients. METHODS This cross-sectional study was performed between 1 January to 31 December 2021. The eligible patients were in either the active or remission stage of GD. The demographic and clinical data of the patients willing to participate in the study were collected, as well as their vitamin D levels. Comparisons of continuous parameters between the active and remission groups were performed using the Mann-Whitney U test, while categorical parameters were performed using the Chi-square test. RESULTS 75 patients were diagnosed with GD, with 54.7% in the active stage. The mean vitamin D level was lower in the active GD group than in the remission GD group (28.23 vs. 31.58 ng/mL, respectively, p-value 0.079). The prevalence of vitamin D deficiency (i.e., serum vitamin D level < 20 ng/mL) in the active GD group was 14.6%, and in the remission GD group was 0% (p-value 0.02). Moreover, there was a significant negative correlation between the serum vitamin D level and serum free T4 level (p-value 0.03). CONCLUSIONS In spite of non-significance, patients with active GD had lower mean vitamin D levels compared to those with remission GD. The prevalence of vitamin D deficiency was significantly higher in the active GD patients. Additionally, a negative correlation between serum vitamin D levels and serum free T4 levels was observed in this study.

UI MeSH Term Description Entries

Related Publications

Natapon Rattanamusik, and Suriyon Uitrakul, and Atchara Charoenpiriya
February 2013, Endocrine,
Natapon Rattanamusik, and Suriyon Uitrakul, and Atchara Charoenpiriya
May 2007, Medicinal chemistry (Shariqah (United Arab Emirates)),
Natapon Rattanamusik, and Suriyon Uitrakul, and Atchara Charoenpiriya
January 2018, European thyroid journal,
Natapon Rattanamusik, and Suriyon Uitrakul, and Atchara Charoenpiriya
May 2014, International journal of rheumatic diseases,
Natapon Rattanamusik, and Suriyon Uitrakul, and Atchara Charoenpiriya
November 2013, Journal of Crohn's & colitis,
Natapon Rattanamusik, and Suriyon Uitrakul, and Atchara Charoenpiriya
January 2022, Annals of gastroenterology,
Natapon Rattanamusik, and Suriyon Uitrakul, and Atchara Charoenpiriya
December 2012, Endocrine,
Natapon Rattanamusik, and Suriyon Uitrakul, and Atchara Charoenpiriya
October 2016, Clinical nephrology,
Natapon Rattanamusik, and Suriyon Uitrakul, and Atchara Charoenpiriya
November 2023, Neuroscience,
Natapon Rattanamusik, and Suriyon Uitrakul, and Atchara Charoenpiriya
June 2000, Thyroid : official journal of the American Thyroid Association,
Copied contents to your clipboard!